Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Resistant Hypertension: full-pipeline trial registry
2 of 5 indexed Resistant Hypertension trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Resistant Hypertension: 5 US clinical trials tracked, 2 recruiting.
Resistant Hypertension is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Vascular Dynamics, running 1 of these trials.
Enrollment posture brief
Registry condition resistant-hypertension
OPEN 2 | RECR 40% | LATE 1 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Resistant Hypertension lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Resistant Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Resistant Hypertension is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Resistant Hypertension research.
Vascular Dynamics accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Resistant Hypertension enrolment sits around 300 participants.
Median target enrolment is 300 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Resistant Hypertension research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
VA Office of Research and Development
NCT05888233
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
DeepQure
NCT06526858
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
Brigham and Women's Hospital
NCT05925569
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Vascular Dynamics
NCT03179800
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
AstraZeneca
NCT06034743
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Resistant Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Resistant Hypertension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Resistant Hypertension page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Resistant Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vascular Dynamics sponsors the most Resistant Hypertension trials on record, review their full trial history before evaluating a specific study. See Vascular Dynamics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Resistant Hypertension condition card totals 5 registered trials; most-linked intervention Best Practice Advisory Computerized Alert; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.